Kvas, E. (2006): [Drug eluting stents in comparison to uncoated stents in the treatment of cardiopathy]. Rapid Assessment LBI-HTA 01.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
In the course of the year 2006 several studies on the safety of DES were presented and discussed at different congresses for cardiologists. The controversial debates led to uncertainties and a reduced use of DES in several countries, esp. Sweden where data from a registry enforced the observations of increased rates of late stent thrombosis. Already earlier assessments presented no difference in mortality between DES and bare metal stents (BMS), more recent analysis showed increased rates of stent-thrombosis esp. in patient with complex conditions and after discontinuation of co-medication.
|Item Type:||Rapid Assessment LBI-HTA|
|Additional Information:||Reviewed by: Univ.-Prof. Dr. D. Glogar, Univ.-Doz. Dr. Dr. hc. Robert D. Fitzgerald|
|Keywords:||Cardiopathy, PCI, drug eluting stents (DES), Sirolimus, Paclitaxel, off-label use, label use, effectiveness, cost effectiveness|
|Subjects:||WG Cardiovascular system|
|Series Name:||Rapid Assessment LBI-HTA|
|Deposited on:||13 Jun 2007 11:36|
|Last Modified:||24 Jan 2008 15:16|
Repository Staff Only: item control page